Rethinking "long term" opioid therapy

BMJ. 2019 Nov 29:367:l6691. doi: 10.1136/bmj.l6691.

Authors

Christina Abdel Shaheed^{1

2}, Andrew J McLachlan³, Chris G Maher^{4

2}

Affiliations

¹ Institute for Musculoskeletal Health, University of Sydney, Sydney, Australia Christina.abdelshaheed@sydney.edu.au.
² School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
³ School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
⁴ Institute for Musculoskeletal Health, University of Sydney, Sydney, Australia.

PMID: 31784472
DOI: 10.1136/bmj.l6691

No abstract available

Publication types

Editorial

MeSH terms

Analgesics, Opioid / administration & dosage*
Chronic Pain / drug therapy*
Drug Administration Schedule
Humans
Opioid-Related Disorders / etiology
Opioid-Related Disorders / prevention & control*
Pain Management / adverse effects
Pain Management / methods*
Substance-Related Disorders / etiology
Substance-Related Disorders / prevention & control*
Time Factors

Substances

Analgesics, Opioid